Page 263 - Read Online
P. 263

Cao                                                                                                                                                                                                                      Cancer Evo-Dev

           2.   Ewald PW. 99th Dahlem conference on infection, inflammation and   Genet 2009;41:591-5.
               chronic  inflammatory  disorders:  symbionts  and  immunopathology   19.  Guo  X,  Zhang  Y,  Li  J,  Ma  J,  Wei  Z,  Tan  W,  O’Brien  SJ.  Strong
               in chronic diseases: insights from evolution.  Clin Exp Immunol   influence  of  human  leukocyte  antigen  (HLA)-DP  gene  variants  on
               2010;160:27-34.                                   development of persistent chronic hepatitis B virus carriers in the Han
           3.   Du Y, Han X, Ding YB, Yin JH, Cao GW. Prediction and prophylaxis   Chinese population. Hepatology 2011;53:422-8.
               of hepatocellular carcinoma occurrence and postoperative recurrence   20.  Li S, Qian J, Yang Y, Zhao W, Dai J, Bei JX, Foo JN, McLaren PJ,
               in chronic hepatitis B virus-infected subjects. World J Gastroenterol   Li Z, Yang J, Shen F, Liu L, Yang J, Li S, Pan S, Wang Y, Li W,
               2016;22:6565-72.                                  Zhai  X,  Zhou  B,  Shi  L,  Chen  X,  Chu  M,  Yan  Y,  Wang  J,  Cheng
           4.   Cho JY, Paik YH, Sohn W, Cho HC, Gwak GY, Choi MS, Lee JH,   S, Shen J, Jia W, Liu J, Yang J, Wen Z, Li A, Zhang Y, Zhang G,
               Koh KC, Paik SW, Yoo BC. Patients with chronic hepatitis B treated   Luo X, Qin H, Chen M, Wang H, Jin L, Lin D, Shen H, He L, de
               with oral antiviral therapy retain a higher risk for HCC compared with   Bakker PI, Wang H, Zeng YX, Wu M, Hu Z, Shi Y, Liu J, Zhou W.
               patients with inactive stage disease. Gut 2014;63:1943-50.   GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for
           5.   Fung AKY, Chong CCN, Lee KF, Wong J, Cheung YS, Fong AKW,   hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS
               Lai  PBS.  Outcomes  of  emergency  and  interval  hepatectomy  for   Genet 2012;8:e1002791.
               ruptured resectable hepatocellular carcinoma: a single tertiary referral   21.  Hu Z, Liu Y, Zhai X, Dai J, Jin G, Wang L, Zhu L, Yang Y, Liu J,
               centre experience. Hepatoma Res 2017;3:196-204.   Chu M, Wen J, Xie K, Du G, Wang Q, Zhou Y, Cao M, Liu L, He Y,
           6.   Chok KSH. Surgical strategy for huge and advanced hepatocellular   Wang Y, Zhou G, Jia W, Lu J, Li S, Liu J, Yang H, Shi Y, Zhou W,
               carcinoma in Hong Kong. Hepatoma Res 2017;3:189-95.   Shen H. New loci associated with chronic hepatitis B virus infection
           7.   Sarkar  J,  DeLeon  T,  Wong  LL.  MELD  score  and  AST-to-platelet   in Han Chinese. Nat Genet 2013;45:1499-503.
               ratio  index  predict  long-term  survival  in  patients  with  a  small   22.  Zhu M, Dai J, Wang C, Wang Y, Qin N, Ma H, Song C, Zhai X,
               hepatocellular carcinoma following non-transplant therapies: a pilot   Yang Y, Liu J, Liu L, Li S, Liu J, Yang H, Zhu F, Shi Y, Shen H,
               study. Hepatoma Res 2017;3:79-85.                 Jin G, Zhou W, Hu Z. Fine mapping the MHC region identified four
           8.   Chen  L,  Zhang  Q,  Chang  W,  Du  Y,  Zhang  H,  Cao  G.  Viral  and   independent variants modifying susceptibility to chronic hepatitis B in
               host  inflammation-related  factors  that  can  predict  the  prognosis  of   Han Chinese. Hum Mol Genet 2016;25:1225-32.
               hepatocellular carcinoma. Eur J Cancer 2012;48:1977-87.  23.  Png E, Thalamuthu A, Ong RT, Snippe H, Boland GJ, Seielstad M.
           9.   Liu WB, Yang F, Shao DY, Cao GW. Novel predictive and prognostic   A genome-wide association study of hepatitis B vaccine response in
               strategies  of hepatitis  B virus related  hepatocellular  carcinoma.   an Indonesian population reveals multiple independent risk variants in
               Hepatoma Res 2016;2:331-40.                       the HLA region. Hum Mol Genet 2011;20:3893-8.
           10.  Aggarwal BB, Vijayalekshmi RV, Sung B. Targeting inflammatory   24.  Tan W, Xia J, Dan Y, Li M, Lin S, Pan X, Wang H, Tang Y, Liu N,
               pathways  for  prevention  and  therapy  of  cancer:  short-term  friend,   Tan S, Liu M, He W, Zhang W, Mao Q, Wang Y, Deng G. Genome-
               long-term foe. Clin Cancer Res 2009;15:425-30.    wide  association  study  identifies  HLA-DR  variants  conferring
           11.  He G, Karin M. NF-κB and STAT3 - key players in liver inflammation   risk  of  HBV-related  acute-on-chronic  liver  failure.  Gut  2017;  pii:
               and cancer. Cell Res 2011;21:159-68.              gutjnl-2016-313035.
           12.  Li  Z,  Hou  X,  Cao  G.  Is  mother-to-infant  transmission  the  most   25.  Jiang DK, Ma XP, Wu X, Peng L, Yin J, Dan Y, Huang HX, Ding DL,
               important factor for persistent HBV infection? Emerg Microbes Infect   Zhang LY, Shi Z, Zhang P, Yu H, Sun J, Lilly Zheng S, Deng G, Xu
               2015;4:e30.                                       J, Liu Y, Guo J, Cao G, Yu L. Genetic variations in STAT4,C2,HLA-
           13.  Zhang HW, Yin JH, Li YT, Li CZ, Ren H, Gu CY, Wu HY, Liang   DRB1 and HLA-DQ associated with risk of hepatitis B virus-related
               XS, Zhang P, Zhao JF, Tan XJ, Lu W, Schaefer S, Cao GW. Risk   liver cirrhosis. Sci Rep 2015;5:16278.
               factors for acute hepatitis B and its progression to chronic hepatitis in   26.  Yu L, Cheng YJ, Cheng ML, Yao YM, Zhang Q, Zhao XK, Liu HJ,
               Shanghai, China. Gut 2008;57:1713-20.             Hu YX, Mu M, Wang B, Yang GZ, Zhu LL, Zhang S. Quantitative
           14.  Yin J, Zhang H, He Y, Xie J, Liu S, Chang W, Tan X, Gu C, Lu W,   assessment of common genetic variations in HLA-DP with hepatitis B
               Wang H, Bi S, Cui F, Liang X, Schaefer S, Cao G. Distribution and   virus infection, clearance and hepatocellular carcinoma development.
               hepatocellular carcinoma-related viral properties of hepatitis B virus   Sci Rep 2015;5:14933.
               genotypes  in  Mainland  China:  a  community-based  study.  Cancer   27.  Jiang DK, Sun J, Cao G, Liu Y, Lin D, Gao YZ, Ren WH, Long XD,
               Epidemiol Biomarkers Prev 2010;19:777-86.         Zhang H, Ma XP, Wang Z, Jiang W, Chen TY, Gao Y, Sun LD, Long
           15.  Yin JH, Zhao J, Zhang HW, Xie JX, Li WP, Xu GZ, Shen J, Dong   JR, Huang HX, Wang D, Yu H, Zhang P, Tang LS, Peng B, Cai H, Liu
               HJ, Zhang J, Wang L, Han JK, Wang HY, Cao GW. HBV genotype   TT, Zhou P, Liu F, Lin X, Tao S, Wan B, Sai-Yin HX, Qin LX, Yin J,
               C  is  independently  associated  with  cirrhosis  in  community-based   Liu L, Wu C, Pei Y, Zhou YF, Zhai Y, Lu PX, Tan A, Zuo XB, Fan J,
               population. World J Gastroenterol 2010;16:379-83.  Chang J, Gu X, Wang NJ, Li Y, Liu YK, Zhai K, Zhang H, Hu Z, Liu
           16.  Chan HL, Wong GL, Tse CH, Chim AM, Yiu KK, Chan HY, Sung   J, Yi Q, Xiang Y, Shi R, Ding Q, Zheng W, Shu XO, Mo Z, Shugart
               JJ, Wong VW. Hepatitis B virus genotype C is associated with more   YY, Zhang XJ, Zhou G, Shen H, Zheng SL, Xu J, Yu L. Genetic
               severe  liver  fibrosis  than  genotype  B.  Clin Gastroenterol Hepatol   variants  in  STAT4  and  HLA-DQ  genes  confer  risk  of  hepatitis  B
               2009;7:1361-6.                                    virus-related hepatocellular carcinoma. Nat Genet 2013;45:72-5.
           17.  Yin J, Zhang H, Li C, Gao C, He Y, Zhai Y, Zhang P, Xu L, Tan   28.  Schaefer  S.  Hepatitis  B  virus  taxonomy  and  hepatitis  B  virus
               X, Chen J, Cheng S, Schaefer S, Cao G. Role of hepatitis B virus   genotypes. World J Gastroenterol 2007;13:14-21.
               genotype  mixture,  subgenotypes  C2  and  B2  on  hepatocellular   29.  Yin J, Xie J, Liu S, Zhang H, Han L, Lu W, Shen Q, Xu G, Dong H,
               carcinoma:  compared  with  chronic  hepatitis  B  and  asymptomatic   Shen J, Zhang J, Han J, Wang L, Liu Y, Wang F, Zhao J, Zhang Q,
               carrier state in the same area. Carcinogenesis 2008;29:1685-91.   Ni W, Wang H, Cao G. Association between the various mutations in
           18.  Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi   viral core promoter region to different stages of hepatitis B, ranging
               A,  Hosono  N,  Kubo  M,  Tsunoda  T,  Kamatani  N,  Kumada  H,   of asymptomatic carrier state to hepatocellular  carcinoma.  Am J
               Puseenam A, Sura T, Daigo Y, Chayama K, Chantratita W, Nakamura   Gastroenterol 2011;106:81-92.
               Y, Matsuda K.A genome-wide association study identifies variants in   30.  Yin J, Xie J, Zhang H, Shen Q, Han L, Lu W, Han Y, Li C, Ni W,
               the HLA-DP locus associated with chronic hepatitis B in Asians. Nat   Wang H, Cao G.Significant association of different preS mutations

                           Hepatoma Research ¦ Volume 3 ¦ October 27, 2017                                255
   258   259   260   261   262   263   264   265   266   267   268